Literature DB >> 105151

Carcinom of the paranasal sinuses--a review of 158 cases.

M W Bridger, F A Beale, D P Bryce.   

Abstract

One hundred and fifty-eight cases of paranasal sinus cancer have been reviewed retrospectively. The actuarial survival at five years for the whole group was 33%. The American Joint Committee (AJC) classification for maxillary cancer was used. T1 and T2 cases, with an actuarial survival of 44% at five years, had a significantly better prognosis than T3 cases (31%) and T4 cases (10%). Anemia of presentation and the presence of persistent disease when surgery followed pre-operative irradiation were poor prognostic indicators. The policy of combined pre-operative irradiation followed by surgery is advocated; patients with anemia should have this corrected before and during treatment.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 105151

Source DB:  PubMed          Journal:  J Otolaryngol        ISSN: 0381-6605


  9 in total

1.  Sinonasal malignancies: long term follow up after surgical management-an analysis of outcomes.

Authors:  K Devaraja; Kapil Sikka; Rajeev Kumar; Alok Thakar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-06-29

2.  Sinonasal tract mucoepidermoid carcinoma: a clinicopathologic and immunophenotypic study of 19 cases combined with a comprehensive review of the literature.

Authors:  Erica B Wolfish; Brenda L Nelson; Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2011-12-20

3.  The treatment of advanced sinonasal malignancies with pre-operative intra-arterial cisplatin and concurrent radiation.

Authors:  L Madison Michael; Jeffrey M Sorenson; Sandeep Samant; Jon H Robertson
Journal:  J Neurooncol       Date:  2005-03       Impact factor: 4.130

4.  Primary sphenoid sinus neoplasms: a report of four cases with common clinical presentation treated with transsphenoidal surgery and adjuvant therapies.

Authors:  Felice Esposito; Daniel F Kelly; Harry V Vinters; Antonio A F DeSalles; Joel Sercarz; Alessandra A Gorgulhos
Journal:  J Neurooncol       Date:  2006-02       Impact factor: 4.130

Review 5.  The skull base, paranasal sinuses, and related malignancies.

Authors:  Chad A Zender; Guy J Petruzzelli
Journal:  Curr Oncol Rep       Date:  2003-03       Impact factor: 5.075

6.  CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract.

Authors:  A Franchi; D Massi; A Palomba; M Biancalani; M Santucci
Journal:  Virchows Arch       Date:  2004-06-03       Impact factor: 4.064

7.  Anterior craniofacial resection - for paranasal sinus tumors involving anterior skull base.

Authors:  Saurabh Varshney; S S Bist; Nitin Gupta; R K Singh; Sanjeev Bhagat
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2010-09-24

8.  Cancer of the NES complex (Nasal Cavity, Ethmoid, Sphenoid Sinuses): A retrospective review.

Authors:  K Bhattacharaya; R K Aich; S K Mondal; P Gupta
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  1999-01

9.  Sinonasal tract and nasopharyngeal adenoid cystic carcinoma: a clinicopathologic and immunophenotypic study of 86 cases.

Authors:  Lester D R Thompson; Carla Penner; Ngoc J Ho; Robert D Foss; Markku Miettinen; Jacqueline A Wieneke; Christopher A Moskaluk; Edward B Stelow
Journal:  Head Neck Pathol       Date:  2013-09-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.